Heat treatment for giant cell tumors of bone: A systematic review.
Carlijn SchoutensFloortje G M VerspoorPublished in: Journal of orthopaedic surgery (Hong Kong) (2023)
This systematic review evaluates the effects of heat treatments in de novo, residual and recurrent giant cell tumors of bone (GCTB). Studies were eligible for inclusion if one of the following treatments was administered: radiofrequency ablation (RFA), microwave ablation, argon cauterization, electrocauterization and hot liquid treatment. The primary outcome was recurrence. Secondary outcomes were complications, pain, function, and quality of life. Recurrence rates for microwave ablation as an adjuvant to intralesional curettage were 0%, 4% and 10% (3 retrospective single-group studies); for argon cauterization 4%, 8% and 26% (3 cohort studies); electrocauterization 0% to 33% (8 cohort studies); and hot liquid 9.5% and 24% (2 cohort studies). Follow-up was generally ≥24 months. Data on pain, function and quality of life were scarce. Complications included infection and secondary osteoarthritis. Current evidence does not demonstrate or exclude an effect of heat treatments on recurrence in GCTB. Further research should objectify if (subgroups of) patients benefit from these treatments.
Keyphrases
- radiofrequency ablation
- giant cell
- systematic review
- chronic pain
- end stage renal disease
- pain management
- newly diagnosed
- bone mineral density
- ionic liquid
- ejection fraction
- free survival
- neuropathic pain
- early stage
- risk factors
- meta analyses
- peritoneal dialysis
- combination therapy
- electronic health record
- atrial fibrillation
- body composition
- soft tissue
- postmenopausal women
- insulin resistance
- bone regeneration
- catheter ablation
- glycemic control